News of two pharma deals involving Novo Nordisk and GSK and a loss for Open AI were also among the top talking points ...
Howard Hogan, IP partner at Gibson Dunn, says AI deepfakes are driving lawyers to rethink how IP protects creativity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback